President Trump is giving drug companies 60 days to their prices. Trump posted on Truth Social letters to the CEOs of companies including Novo Nordisk, Eli Lilly, GlaxoSmithKline, Abbvie and Pfizer demanding a "binding commitment" to the most-favored nation policy withinthat deadline. Dr. William Soliman, CEO at Accreditation Council for Medical Affairs (ACMA) weighs in.

See Full Page